Florent Le Prado's areas of practice include venture capital, private equity, M&A, and capital markets. He primarily represents high-growth listed and unlisted companies, their managers, and the private equity and industrial investors that finance them at every stage of their development from entrepreneurial start-ups to global corporations.
Florent's recent experience includes representing Adikteev, Alizé Pharma, Cellectis, EasyVista, ETS Global, Eurobio Scientific, Inside Secure, Ivalua, Lacroix Group, Ouicar, Pharnext, SuperSonic Imagine, TxCell, Urban Canopée, and Welcome to the Jungle. Investor-side, he also has represented, among others, Alven Capital Partners, Bpifrance, ChapsVision, Creadev (Mulliez family), Elaia Partners, Idinvest Partners, New Alpha Asset Management, Open CNP, Portage Ventures, Ring Capital, Seventure Partners, and Temasek.
Transactions in which Florent has advised include the tender offers on EasyVista, SuperSonic Imagine, Coheris, TxCell, and Orolia; the initial public offerings (IPOs) of Medincell and Pharnext; the leveraged buyouts (LBOs) of EasyVista by Eurazeo, Brico Privé by Florac, and Orolia by Eurazeo; the latest financing rounds of Actility, Contentsquare, InnovaFeed, Ivalua, Urban Canopée, UroMems, and Welcome to the Jungle; the acquisitions of eSoftThings by Lacroix Group and Pipplet by ETS Global; and the sale of Alizé Pharma to Millendo.
- ESSEC Business School (M.Sc. in Management 2014); Paris Bar School (CAPA 2013); University of Paris II-Panthéon Assas (Master 2 in Business Law 2010)
- Gold Trophy in Venture Capital & Capital Development at the 2017 Trophées du Droit ceremony for the 7th time in a row (biennially since 2005) — Décideurs Magazine, Paris
- French and English